MedTrace Logo

PENG Block for Arthroscopic Hip Surgery

NCT04508504 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-03-25

No results posted yet for this study

Summary

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the analgesic efficacy of the pericapsular nerve group block in the setting of outpatient hip arthroscopy.

Conditions

  • Postoperative Pain
  • Hip Arthroscopy

Interventions

PROCEDURE

Preop PENG block

Ultrasound-guided injection of 20 mL 0.5% ropivacaine according to the method described by Giron-Arango L in 2018. A needle is inserted at the inguinal level under ultrasound guidance to pass beneath the psoas tendon on top of the iliopubic eminence where the local anesthetic is injected.

PROCEDURE

Placebo block

Ultrasound-guided placebo injection of 5 mL 0.9% normal saline. Using the same landmarks as for the PENG group, a needle is inserted in the inguinal region under ultrasound guidance, whereby a subcutaneous injection of 5 mL of 0.9% saline is made.

DRUG

Ropivacaine 0.5% Injectable Solution

20 mL 0.5% ropivacaine will be injected for the preop PENG block

DRUG

Normal Saline

5 mL 0.9% Normal saline will be injected for the Placebo block

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Peter E Amato, MD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-02-01
Completion
2022-02-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04508504 on ClinicalTrials.gov